|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.2450 SEK | -5.04% |
|
-0.41% | -8.58% |
| 08-13 | Acarix AB, Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | Acarix AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Diagnostic & Testing Equipment
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 30.59M | - | - | - | ||
| 17.1B | |||||
| 1.76B | - | - | |||
| 985M | |||||
| 981M | - | ||||
| 779M | - | - |
- Stock Market
- Stocks
- ACARIX Stock
- Charts Acarix AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
